Research roundup


Debbie Rigby rounds up the latest in research news Risk of gastrointestinal bleeding by specific SSRIs and SNRIs A systematic review of 20 studies has concluded all selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) have an increased risk of gastrointestinal bleeding, ranging from 31% to a 50%. Venlafaxine had the highest estimated

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Extending prac payments ‘not optional’
Next ‘Lack of controls’: Are GLP-1s being prescribed to vulnerable patients?